FAKTOR OPTIONSSCHEIN - MERCK & CO. | Real-time Bid/Ask 03:18:28 2024-05-17 am EDT | ||
| 6.43 EUR / 6.73 EUR | +1.54% |
|
| Current month | -8.86% | ||
| 1 month | -19.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 6.45 | -0.46% |
| 24-05-16 | 6.48 | +1.25% |
| 24-05-15 | 6.4 | -9.22% |
| 24-05-14 | 7.05 | 0.00% |
| 24-05-13 | 7.05 | +4.75% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 02:10 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM14VS |
| ISIN | DE000UM14VS7 |
| Date issued | 2024-02-20 |
| Strike | 163.6 $ |
| Maturity | Unlimited |
| Parity | 4.57 : 1 |
| Emission price | 7.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.57 € |
|---|---|
| Lowest since issue | 6.19 € |
| Spread | 0.3 € |
| Spread % | 4.46% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.9
USD
Average target price
141.6
USD
Spread / Average Target
+8.22%
- Stock Market
- Certificates
- Certificat
